Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study. Dirix LY, Takacs I, Jerusalem… Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer. Yardley DA, Arrowsmith ER, Daniel BR, Eakle J, Brufsky A,… TITAN: phase III study of doxorubicin/cyclophosphamide
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.… Final overall survival analysis for the phase II RECORD-3
The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer. Page RD, Argento AC, Nash DB, Skoufalos A, Schaefer… The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial. O’Shaughnessy J, Petrakova K,… Ribociclib plus Letrozole
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). Awad MM, Chu… Phase II SCLC Study
The DART Study: Results from the Dose-Escalation and Expansion Cohorts Evaluating the Combination of Dalantercept plus Axitinib in Advanced Renal Cell Carcinoma. Voss MH, Bhatt… The DART Study
Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. Rugo HS, Seneviratne… Prevention of everolimus-related stomatitis
Managing Expectations in the Transition to Proof of Concept Studies. Kieber-Emmons T, Makhoul I, Pennisi A, Siegel ER, Emanuel PD, Monzavi-Karbassi B, Steplewski Z, Beck… Managing Expectations in the Transition to Proof of Concept Studies
The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer. Page RD, Argento AC, Nash DB, Skoufalos A, Schaefer… The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung Cancer